Role of erlotinib in the targeted treatment of non-small-cell lung cancer in Chinese patients

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been demonstrated to improve responses and clinical outcomes significantly in patients with advanced non-small-cell lung cancer (NSCLC). In retrospective subgroup analyses of several studies, patients with Asian ethnicity...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wei, Zhou, Fei, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928465/
https://www.ncbi.nlm.nih.gov/pubmed/24611018
http://dx.doi.org/10.2147/OTT.S45096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3928465/
https://www.ncbi.nlm.nih.gov/pubmed/24611018
http://dx.doi.org/10.2147/OTT.S45096

Ejemplares similares